Free Trial

Riot Platforms (RIOT) Competitors

Riot Platforms logo
$12.15 -0.12 (-0.98%)
(As of 11/20/2024 ET)

RIOT vs. VIVO, OSTK, OXFD, AWH, SOFI, ALLY, UWMC, BSAC, WF, and CIB

Should you be buying Riot Platforms stock or one of its competitors? The main competitors of Riot Platforms include Meridian Bioscience (VIVO), Overstock.com (OSTK), Oxford Immunotec Global (OXFD), Aspira Women's Health (AWH), SoFi Technologies (SOFI), Ally Financial (ALLY), UWM (UWMC), Banco Santander-Chile (BSAC), Woori Financial Group (WF), and Bancolombia (CIB).

Riot Platforms vs.

Meridian Bioscience (NASDAQ:VIVO) and Riot Platforms (NASDAQ:RIOT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, community ranking, institutional ownership and dividends.

Meridian Bioscience has higher revenue and earnings than Riot Platforms. Riot Platforms is trading at a lower price-to-earnings ratio than Meridian Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meridian Bioscience$333.02M4.49$42.46M$0.9735.02
Riot Platforms$280.70M14.38-$49.47M$1.518.05

Riot Platforms has a consensus target price of $16.35, suggesting a potential upside of 34.57%. Given Riot Platforms' stronger consensus rating and higher possible upside, analysts clearly believe Riot Platforms is more favorable than Meridian Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Meridian Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Riot Platforms
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.09

Meridian Bioscience has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Riot Platforms has a beta of 4.08, indicating that its share price is 308% more volatile than the S&P 500.

Riot Platforms received 203 more outperform votes than Meridian Bioscience when rated by MarketBeat users. Likewise, 68.29% of users gave Riot Platforms an outperform vote while only 48.69% of users gave Meridian Bioscience an outperform vote.

CompanyUnderperformOutperform
Meridian BioscienceOutperform Votes
316
48.69%
Underperform Votes
333
51.31%
Riot PlatformsOutperform Votes
519
68.29%
Underperform Votes
241
31.71%

89.7% of Meridian Bioscience shares are owned by institutional investors. Comparatively, 40.3% of Riot Platforms shares are owned by institutional investors. 2.3% of Meridian Bioscience shares are owned by insiders. Comparatively, 6.9% of Riot Platforms shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Riot Platforms has a net margin of 115.35% compared to Meridian Bioscience's net margin of 12.70%. Meridian Bioscience's return on equity of 16.74% beat Riot Platforms' return on equity.

Company Net Margins Return on Equity Return on Assets
Meridian Bioscience12.70% 16.74% 13.09%
Riot Platforms 115.35%14.89%14.01%

In the previous week, Riot Platforms had 3 more articles in the media than Meridian Bioscience. MarketBeat recorded 3 mentions for Riot Platforms and 0 mentions for Meridian Bioscience. Riot Platforms' average media sentiment score of 0.88 beat Meridian Bioscience's score of 0.00 indicating that Riot Platforms is being referred to more favorably in the news media.

Company Overall Sentiment
Meridian Bioscience Neutral
Riot Platforms Positive

Summary

Riot Platforms beats Meridian Bioscience on 14 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RIOT vs. The Competition

MetricRiot PlatformsNondepository credit institutions IndustryBusiness SectorNASDAQ Exchange
Market Cap$4.04B$8.04B$6.93B$8.82B
Dividend YieldN/A5.19%2.92%4.07%
P/E Ratio8.0516.6846.0917.74
Price / Sales14.3815.55203.9474.25
Price / Cash12.6042.0424.3332.53
Price / Book1.332.555.084.68
Net Income-$49.47M$462.43M$121.42M$226.08M
7 Day Performance-4.10%-0.27%-1.11%-2.03%
1 Month Performance23.23%24.94%8.17%0.07%
1 Year Performance7.33%107.16%29.60%24.61%

Riot Platforms Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RIOT
Riot Platforms
4.1524 of 5 stars
$12.15
-1.0%
$16.35
+34.6%
+7.3%$4.08B$312.91M8.05340Insider Trade
Gap Up
VIVO
Meridian Bioscience
1.0351 of 5 stars
$33.97
flat
N/AN/A$1.50B$333.02M35.02702Analyst Forecast
OSTK
Overstock.com
N/AN/AN/AN/A$760.30M$1.93B-4.671,050Gap Up
OXFD
Oxford Immunotec Global
N/A$21.99
flat
N/AN/A$570.90M$73.71M-439.80273Analyst Forecast
AWH
Aspira Women's Health
1.5354 of 5 stars
$0.73
+2.8%
$4.40
+502.7%
-78.5%$11.44M$9.15M0.00110Analyst Forecast
Gap Up
SOFI
SoFi Technologies
2.423 of 5 stars
$14.67
+1.7%
$9.80
-33.2%
+121.8%$15.65B$2.12B146.714,400Analyst Forecast
ALLY
Ally Financial
4.977 of 5 stars
$35.53
-0.1%
$40.69
+14.5%
+28.6%$10.83B$8.21B14.2111,100
UWMC
UWM
2.9797 of 5 stars
$6.07
-2.7%
$7.53
+24.1%
+7.0%$9.97B$1.31B0.006,700Options Volume
BSAC
Banco Santander-Chile
4.2727 of 5 stars
$19.52
+1.3%
$21.50
+10.1%
+1.7%$9.08B$6.07B11.099,229Positive News
WF
Woori Financial Group
3.8453 of 5 stars
$35.44
+0.6%
N/A+20.5%$8.72B$17.78B4.61150
CIB
Bancolombia
1.4595 of 5 stars
$33.49
+1.7%
$33.67
+0.5%
+21.9%$7.92B$27.76T5.3134,756Positive News

Related Companies and Tools


This page (NASDAQ:RIOT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners